Praj Industries to participate in Ashwamedh-Elara investor dialogue

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Praj Industries to attend Ashwamedh-Elara India Dialogue 2026
  • Conference scheduled for September 2, 2026, in Mumbai
  • Event organized by Elara Capital at Grand Hyatt
  • Company confirms no UPSI will be disclosed
powered bylight_fuzz_icon
49111276

*this image is generated using AI for illustrative purposes only.

Praj Industries will participate in the Ashwamedh-Elara India Dialogue 2026 investor conference on September 2, 2026, in Mumbai.

The event is organized by Elara Capital and will be held at the Grand Hyatt in Santacruz. Praj Industries stated that no unpublished price-sensitive information (UPSI) will be discussed during the interactions.

Regulatory Disclosure

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The disclosure was signed by Anant Bavare, Company Secretary and Compliance Officer of Praj Industries.

Historical Stock Returns for Praj Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.44%-5.69%-1.68%+2.60%-18.08%0.0%

How might Praj Industries' participation in the Ashwamedh-Elara India Dialogue influence investor sentiment towards the bio-energy sector in Q4 2026?

What specific strategic initiatives or expansion plans could Praj Industries highlight to differentiate itself from competitors during this high-profile investor conference?

Could the absence of unpublished price-sensitive information (UPSI) limit the immediate market impact of Praj Industries' presentation, and how should investors interpret the management's commentary?

Praj Industries Q1FY27 revenue up 11.8% to ₹7,158 crore; order intake hits ₹10,000 crore

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Praj Industries reported Q1FY27 consolidated revenue of ₹7,158 crore, up 11.8% YoY, with net profit doubling to ₹116 crore. Order intake surged 25.8% to ₹10,000 crore, bolstered by wins in Brazil and data centers. Management highlighted margin pressures from material costs but pointed to new verticals like Bio-IBA and SAF as growth drivers. Cash reserves stand at ₹6,160 crore, and a 180% dividend was approved.

powered bylight_fuzz_icon
47634503

*this image is generated using AI for illustrative purposes only.

Praj Industries Limited has released its unaudited financial results and investor presentation for the quarter ended June 30, 2026 (Q1FY27). The industrial biotechnology firm logged consolidated revenue of ₹7,158 crore, a 11.8% increase from ₹6,402 crore in the corresponding period of the previous fiscal year. This growth underscores continued demand for its ethanol and renewable energy solutions amidst India’s expanding bioeconomy sector.

The most striking feature of the quarter was the surge in bottom-line performance. Praj Industries reported a consolidated net profit of ₹116 crore, more than doubling the ₹53 crore recorded in Q1FY26. Standalone net profit also rose 27.0% to ₹254 crore from ₹200 crore. While operating margins faced pressure, the significant jump in net profit indicates benefits from other income or improved tax efficiency.

Financial Performance Overview

Metric Q1FY27 Q1FY26 Change
Revenue (Consolidated) ₹7,158 crore ₹6,402 crore +11.8%
EBITDA (Consolidated) ₹300 crore ₹314 crore -4.5%
EBITDA Margin (Consolidated) 4.19% 4.90% -71 bps
Net Profit (Consolidated) ₹116 crore ₹53 crore +118.9%
Order Intake ₹10,000 crore ₹7,950 crore +25.8%
Order Backlog ₹45,890 crore ₹44,480 crore +3.2%

The divergence between declining EBITDA and surging net profit warrants attention. EBITDA stood at ₹300 crore for the quarter, down from ₹314 crore year-on-year, causing the EBITDA margin to contract to 4.19% from 4.90%. However, other income contributed significantly, rising to ₹200 crore from ₹86 crore in the consolidated books. In standalone figures, other income jumped 121.2% to ₹292 crore from ₹132 crore, driving the standalone PAT margin expansion to 4.71% from 3.92% despite a 27.1% fall in standalone EBITDA to ₹204 crore.

Segmental Performance and Order Book

Bioenergy remained the dominant revenue contributor, accounting for 66% of total revenue, followed by Engineering at 22% and HiPurity at 12%. Bioenergy revenue grew 23.9% to ₹4,740 crore, while Engineering revenue declined 14.3% to ₹1,570 crore. HiPurity revenue increased 14.6% to ₹850 crore.

Order inflow accelerated significantly in Q1FY27. The company secured order intake of ₹10,000 crore, up from ₹7,950 crore in Q1FY26. This pushed the total order backlog to ₹45,890 crore as on June 30, 2026, compared to ₹44,480 crore in the previous quarter-end. Bioenergy constituted 62% of new orders, while Engineering accounted for 28%. Geographically, domestic orders made up 57% of the intake, with exports contributing 43%.

Management noted that while domestic first-generation ethanol greenfield projects slowed due to funding issues and supply-demand imbalances, demand for brownfield solutions and greenfield ENA plants remained strong. Export revenues accounted for 25% of total revenue in the quarter, lower than the previous year due to execution cycles, but international orders constituted 43% of the new intake, suggesting potential revenue conversion in future quarters.

Strategic Developments and New Verticals

Praj Industries inaugurated the Dr. Pramod Chaudhari Centre of Excellence for Advanced Bioeconomy at Savitribai Phule Pune University on August 10, 2026, aimed at fostering interdisciplinary research. The company received an order to set up India’s first commercial demo plant for Bio-IBA (Bio-Isobutanol alcohol), which is expected to be completed by December 2026. A 2% blending mandate for Bio-IBA in diesel could create over ₹3,000 crore in project opportunities.

In international markets, Praj secured an order for a greenfield grain-to-ethanol plant in Brazil with a capacity of approximately 800 KLPD. The company also received an order for detailed engineering for an ethanol-to-SAF (Sustainable Aviation Fuel) plant from an international customer, following ICAO’s approval of sugarcane-based SAF pathways.

A significant diversification move came through Praj GenX, which signed an exclusive framework agreement with a leading EPC to supply precision fabrication components for hyperscale data center infrastructure. This agreement guarantees a minimum business volume of $50 million over the next two and a half years, with potential upside. Management indicated that Praj GenX aims to achieve EBITDA breakeven by the end of FY27. Additionally, Praj HiPurity Systems secured its first combined contract for ultrapure water and ZLD solutions for a semiconductor company in India.

On the Compressed Bio-Gas (CBG) front, the Union Cabinet approved the GOBARdhan scheme with an outlay of over ₹23,000 crore, aiming to scale domestic CBG production tenfold by FY2036. Praj highlighted its proven technology across multiple feedstocks, including press mud, rice straw, and Napier grass, positioning itself to leverage this policy tailwind.

What the Numbers Show

The financial data presents a mixed operational picture where top-line growth is driven by high-margin segments like Bioenergy, but overall operating leverage is constrained by lower-margin engineering projects or input cost pressures. CFO Sachin Raole attributed margin compression to higher material costs (up nearly 10% YoY) and a shift in export mix towards lower-margin African markets. However, the substantial rise in other income, which constitutes a large portion of the pre-tax profit, highlights that the bottom-line improvement is not solely operational. Investors should monitor the sustainability of this margin profile as the company scales, particularly given the stable order backlog which provides visibility into future revenues.

Cash Position and Dividend

Cash in hand stood at ₹6,160 crore as on June 30, 2026. In its AGM held prior to the earnings call, shareholders approved a final dividend of 180% per share.

Earnings Call Details

Praj Industries hosted an analysts' call on August 14, 2026, at 12:00 pm IST to discuss these un-audited financial results. The conference provided investors with a direct channel to management regarding the company's performance in Q1FY27.

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Anant Narayan Bavare, Company Secretary and Compliance Officer of Praj Industries Limited, signed the disclosure on August 18, 2026.

Management Representation

The management team representing Praj Industries Limited during the conference call includes:

Executive Name Designation
Ashish Gaikwad Managing Director
Sachin Raole Joint Managing Director & CFO

Conference Call Logistics

Investors and analysts joined the call via dial-in numbers provided for India, Singapore, Hong Kong, the UK, and the USA.

Region Contact Number
India (Conference Dial-in) +91 22 6280 1341
India (Access) +91 22 7115 8242
Singapore (Toll Free) 8001012045
Hong Kong (Toll Free) 800964448
UK (Toll Free) 08081011573
USA (Toll Free) 18667462133

For further assistance, investors may contact Sandip Bhadkamkar or Surendra Khairnar at Praj Industries Limited, or Mr. Anuj Sonpal from Investor Relations at Valorem Advisors.

Historical Stock Returns for Praj Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.44%-5.69%-1.68%+2.60%-18.08%0.0%

How sustainable is Praj Industries' bottom-line growth given that the net profit surge was primarily driven by a spike in 'other income' rather than operational EBITDA expansion?

What specific strategies is management implementing to mitigate the impact of rising material costs and the shift toward lower-margin export markets in Africa?

To what extent will the new ₹23,000 crore GOBARdhan scheme and potential Bio-IBA blending mandates contribute to Praj's revenue mix over the next three to five years?

More News on Praj Industries

1 Year Returns:-18.08%